Patents by Inventor Michael Edward Parsons

Michael Edward Parsons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors
    Patent number: 4104382
    Abstract: Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors by administering an antihistamine and an H-2 histamine receptor inhibitor. Exemplary of the antihistamine in the compositions and methods of this invention is mepyramine and exemplary of the H-2 histamine receptor inhibitor is N-cyano-N'-methyl-N"-[2-((4-methyl-5-imidazolyl)-methylthio)ethyl]guanidin e.
    Type: Grant
    Filed: September 27, 1976
    Date of Patent: August 1, 1978
    Assignee: Smith Kline & French Laboratories Limited
    Inventors: James Whyte Black, Michael Edward Parsons
  • Certain N,N'-disubstituted guanidine compounds and their use
    Patent number: 4013659
    Abstract: N-(4-Imidazolyl)propyl-N'-heterocyclomethylthioethyl guanidines which are selective histamine H.sub.2 -receptor agonists.
    Type: Grant
    Filed: December 15, 1975
    Date of Patent: March 22, 1977
    Assignee: Smith Kline & French Laboratories Limited
    Inventors: Graham John Durant, Charon Robin Ganellin, Michael Edward Parsons
  • Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors
    Patent number: 4000302
    Abstract: Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors by administering an antihistamine and an H-2 histamine receptor inhibitor. Exemplary of the antihistamine in the compositions and methods of this invention is mepyramine and exemplary of the H-2 histamine receptor inhibitor is N-cyano-N'-methyl-N"-[2-((4-methyl-5-imidazolyl)-methylthio)ethyl]guanidin e.
    Type: Grant
    Filed: April 16, 1975
    Date of Patent: December 28, 1976
    Assignee: Smith Kline & French Laboratories Limited
    Inventors: James Whyte Black, Michael Edward Parsons
  • Pharmaceutical compositions and method of inhibiting H-1 and H-2 histamine receptors
    Patent number: 3954982
    Abstract: Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors by administering an antihistamine and an H-2 histamine receptor inhibitor. Exemplary of the antihistamine in the compositions and methods of this invention is mepyramine and exemplary of the H-2 histamine receptor inhibitor is N-methyl-N'-[4-(5)-imidazolyl)butyl]thiourea.
    Type: Grant
    Filed: April 16, 1975
    Date of Patent: May 4, 1976
    Assignee: Smith Kline & French Laboratories Limited
    Inventors: James Whyte Black, Michael Edward Parsons